DK307182A - Fremgangsmaade til paavisning af tilstedevaerelsen af et cancerangreb - Google Patents

Fremgangsmaade til paavisning af tilstedevaerelsen af et cancerangreb Download PDF

Info

Publication number
DK307182A
DK307182A DK307182A DK307182A DK307182A DK 307182 A DK307182 A DK 307182A DK 307182 A DK307182 A DK 307182A DK 307182 A DK307182 A DK 307182A DK 307182 A DK307182 A DK 307182A
Authority
DK
Denmark
Prior art keywords
attack
procedure
determining
Prior art date
Application number
DK307182A
Other languages
English (en)
Inventor
J G Bekesi
J F Holland
P H Tsang
Original Assignee
Sinai School Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinai School Medicine filed Critical Sinai School Medicine
Publication of DK307182A publication Critical patent/DK307182A/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57469—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving tumor associated glycolinkage, i.e. TAG
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Physiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • External Artificial Organs (AREA)
DK307182A 1981-07-21 1982-07-08 Fremgangsmaade til paavisning af tilstedevaerelsen af et cancerangreb DK307182A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/285,587 US4455379A (en) 1981-07-21 1981-07-21 Leukocyte adherence inhibition assay

Publications (1)

Publication Number Publication Date
DK307182A true DK307182A (da) 1983-01-22

Family

ID=23094897

Family Applications (1)

Application Number Title Priority Date Filing Date
DK307182A DK307182A (da) 1981-07-21 1982-07-08 Fremgangsmaade til paavisning af tilstedevaerelsen af et cancerangreb

Country Status (7)

Country Link
US (1) US4455379A (da)
JP (1) JPS5873867A (da)
AU (1) AU8598082A (da)
BE (1) BE893900A (da)
CA (1) CA1186989A (da)
DK (1) DK307182A (da)
NL (1) NL8202945A (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0147689B1 (en) * 1983-12-05 1990-09-19 Asahi Kasei Kogyo Kabushiki Kaisha A method of inducing antitumor immunocytes, and a process for producing antitumor immunocytes and antitumor immunocytes produced by the process
EP0154499B1 (en) * 1984-02-29 1989-08-02 Gross, Albert A., trading as Diagnostic Immunology Research Associates Method for diagnosis of a.i.d.s.
US4716107A (en) * 1984-02-29 1987-12-29 Gross Robert L Method for diagnosis of A.I.D.S.
IT1204775B (it) * 1986-01-31 1989-03-10 Rosella Silvestrini Kit per la determinazione dell'attivita' proliferativa nei tumori umani
WO1988000344A1 (en) * 1986-07-03 1988-01-14 Bio-Rad Laboratories, Inc. Peptide fragments of organ-specific neoantigens
US5279968A (en) * 1989-07-20 1994-01-18 Syncor International Corporation Method of labelling leucocytes with Tc-99m, d,1-HMPAO
US5900377A (en) * 1997-03-03 1999-05-04 Syncor International Corporation Method for isolating and radiolabeling leukocytes for use in vivo
CN114075545A (zh) * 2020-08-11 2022-02-22 河南省肿瘤医院 一种抗病毒特异性t细胞的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3999944A (en) * 1975-02-28 1976-12-28 Hoffmann-La Roche Inc. Detection of breast cancer
US4140753A (en) * 1976-04-30 1979-02-20 Scripps Clinic & Research Foundation Diagnostic method and reagent
US4243582A (en) * 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage
US4311686A (en) * 1979-04-30 1982-01-19 The Immunology Development Corporation Methodology for the immunodiagnosis of multiple sclerosis and/or malignant diseases from blood sample analysis
US4294818A (en) * 1979-07-30 1981-10-13 University Patents, Inc. Methods and materials for detection of multiple sclerosis

Also Published As

Publication number Publication date
CA1186989A (en) 1985-05-14
JPS5873867A (ja) 1983-05-04
AU8598082A (en) 1983-01-27
BE893900A (fr) 1982-11-16
US4455379A (en) 1984-06-19
NL8202945A (nl) 1983-02-16

Similar Documents

Publication Publication Date Title
DK65882A (da) Fremgangsmaade til fremstilling af substituerede phosphonamider
DK260682A (da) Fremgangsmaade til fremstilling af partikelformige geler
DK149949C (da) Analogifremgangsmaade til fremstilling af n-aryl-piperazinalkanamider
DK286781A (da) Fremgangsmaade til fremstilling af silazanpolymere
DK469784D0 (da) Fremgangsmaade ved maaling af afstanden til et objekt
DK161482A (da) Fremgangsmaade til fremstilling af et analgetisk praeparat
DK407583A (da) Fremgangsmaade ved og anlaeg til bestemmelse af lerholdige formationers karakteristika
DK153282A (da) Fremgangsmaade til fremstilling af bismethinisoindoliner
DK243783D0 (da) Fremgangsmade til brydning af emulsioner
DK271282A (da) Fremgangsmaade til fremstilling af hidtil ukendte forbindelser af arylbenzulfonamidtypen
DK30781A (da) Fremgangsmaade til fremstilling af triazolidinderivater
DK127482A (da) Fremgangsmaade til fremstilling af dipeptidforbindelser
DK239382A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK305982A (da) Fremgangsmaade til fremstilling af amidobenzamider
DK307182A (da) Fremgangsmaade til paavisning af tilstedevaerelsen af et cancerangreb
DK309282A (da) Fremgangsmaade til fremstilling af et analgetisk praeparat
DK364481A (da) Fremgangsmaade til fremstilling af caprylolactamer
DK46781A (da) Fremgangsmaade til fremstilling af antirhinovirusmidler
DK296281A (da) Fremgangsmaade til fremstilling af aminocyklopentanonamider
DK331282A (da) Fremgangsmaade til fremstilling af hidtil ukendte benztriazoler
DK579181A (da) Fremgangsmaade til fremstilling af diarylthiophener
DK96881A (da) Fremgangsmaade til fremstilling af et angiotensinomdannende enzym
DK507282A (da) Fremgangsmaade til fremstilling af azinorifamycin forbindelser
DK33181A (da) Fremgangsmaade til fremstilling af et interferonlignende protein
DK153841C (da) Fremgangsmaade til fremstilling af ranitidin

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment